HOUSTON, Dec. 18,
2023 /PRNewswire/ -- Nutex Health Inc. ("Nutex
Health" or the "Company") (NASDAQ: NUTX), a physician-led,
technology-enabled integrated healthcare delivery system comprised
of 22 state-of-the-art micro hospitals in 8 states and primary
care-centric, risk-bearing physician networks, today announced that
Thomas Vo, M.D., MBA, Founder,
Chairman and CEO and Warren
Hosseinion, M.D., President, will be participating in the
42nd Annual J.P. Morgan Healthcare Conference on
January 10 and January 11 in San
Francisco, California.
Nutex Health Presentation Details:
Date: Thursday, January 11,
2024
Time: 9:00 AM – 9:40 AM Pacific Time
Venue: Westin St. Francis Hotel in San
Francisco
In addition to the formal presentation, Company management will
be available to participate in one-on-one meetings with qualified
members of the investor community who are registered to attend the
conference.
About Nutex Health Inc.
Headquartered in Houston, Texas
and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a
healthcare management and operations company with two divisions: a
Hospital Division and a Population Health Management Division.
The Hospital Division owns, develops and operates innovative
health care models, including micro-hospitals, specialty hospitals,
and hospital outpatient departments (HOPDs). This division owns and
operates 22 facilities in 8 states.
The Population Health Management division owns and operates
provider networks such as Independent Physician Associations
(IPAs). Through our Management Services Organization (MSO), we
provide management, administrative and other support services to
our affiliated hospitals and physician groups. Our cloud-based
proprietary technology platform aggregates clinical and claims data
across multiple settings, information systems and sources to create
a holistic view of patients and providers, allowing us to deliver
greater quality care more efficiently.
Forward-Looking Statements
Certain statements and information included in this press
release constitute "forward-looking statements" within the meaning
of the Private Securities Litigation Act of 1995. When used in this
press release, the words or phrases "will", "will likely result,"
"expected to," "expects to," "will continue," "anticipated,"
"estimate," "projected," "intend," "goal," or similar expressions
are intended to identify "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995.
Such statements are subject to certain risks, known and unknown,
and uncertainties, many of which are beyond the control of the
Company. Such uncertainties and risks include, but are not
limited to, our ability to successfully execute our growth
strategy, changes in laws or regulations, including final rules
implemented under the No Surprises Act and related regulatory
guidance, economic conditions, dependence on management, dilution
to stockholders, lack of capital, the effects of rapid growth upon
the Company and the ability of management to effectively respond to
the growth and demand for products and services of the Company,
newly developing technologies, the Company's ability to compete,
conflicts of interest in related party transactions, regulatory
matters, protection of technology, lack of industry standards, the
effects of competition and the ability of the Company to obtain
future financing. An extensive list of factors that can affect
future results are discussed in the Current Report on Form 10-Q for
the period ended September 30, 2023
under the heading "Risk Factors" in Part I, Item IA thereof, and
other documents filed from time to time with the Securities and
Exchange Commission. Such factors could materially adversely affect
the Company's financial performance and could cause the Company's
actual results for future periods to differ materially from any
opinions or statements expressed within this press release.
View original
content:https://www.prnewswire.com/news-releases/nutex-health-to-present-at-the-42nd-annual-jp-morgan-healthcare-conference-302017519.html
SOURCE Nutex Health, Inc.